Prediction of long-term treatment outcome in HCV following 24 day PEG-IFN alpha-2b therapy using population pharmacokinetic-pharmacodynamic mixture modeling and classification analysis (Q739328): Difference between revisions
From MaRDI portal
Changed an Item |
Changed an Item |
||
Property / describes a project that uses | |||
Property / describes a project that uses: NONMEM / rank | |||
Normal rank |
Revision as of 02:00, 29 February 2024
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Prediction of long-term treatment outcome in HCV following 24 day PEG-IFN alpha-2b therapy using population pharmacokinetic-pharmacodynamic mixture modeling and classification analysis |
scientific article |
Statements
Prediction of long-term treatment outcome in HCV following 24 day PEG-IFN alpha-2b therapy using population pharmacokinetic-pharmacodynamic mixture modeling and classification analysis (English)
0 references
18 August 2016
0 references
PKPD modeling
0 references
HCV
0 references
mixture modeling
0 references